Gelteq Limited Ordinary Shares
GELSNASDAQHealthcare● Active
$0.48
$-0.02(-3.40%)
Market Cap$4407659
P/E Ratio—
52W High$3.51
52W Low$0.387
Gelteq Limited Ordinary Shares (GELS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GELS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.17M | $0.00M | $0.08M | $0.15M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.05M | $0.09M | $0.00M |
| Gross Profit | $0.17M | $0.00M | $0.03M | $0.05M | $0.00M |
| Gross Margin %(computed) | 100.00% | — | 38.72% | 35.69% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.63M | $0.28M | $0.67M | $0.53M | $0.28M |
| G&A Expenses | $2.02M | $1.25M | $1.53M | $1.48M | $0.45M |
| Total Operating Expenses | $5.66M | $2.95M | $3.13M | $3.25M | $0.65M |
| Operating Income | ($5.50M) | ($2.95M) | ($3.10M) | ($3.19M) | ($0.65M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $1.89M | $0.59M | $0.40M | $0.17M | $0.00M |
| Income Before Tax | ($6.65M) | ($3.55M) | ($3.51M) | ($3.37M) | ($0.65M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($6.65M) | ($3.55M) | ($3.51M) | ($3.37M) | ($0.65M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.00 | $0.00 | $-0.37 | $-0.36 | $-0.07 |
| Wtd Avg Shares | 0.00M | 0.00M | 9.44M | 9.44M | 9.44M |
| EBITDA | ($3.53M) | ($1.75M) | ($1.88M) | ($1.98M) | ($0.59M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · AUD · M
Explore more Gelteq Limited Ordinary Shares data
About Gelteq Limited Ordinary Shares (GELS) Income Statement
Gelteq Limited Ordinary Shares (GELS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GELS reported revenue of $0.00B, gross profit of $0.00B (gross margin 100.00%), and net income of ($0.01B) — a net profit margin of -4011.86%.
Frequently asked questions
GELS · 4 questionsGelteq Limited Ordinary Shares (GELS) reported revenue of $0.00B for 2025, up —% year-over-year.
GELS revenueGELS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08